Definition of the Post-COVID syndrome using a symptom-based Post-COVID score in a prospective, multi-center, cross-sectoral cohort of the German National Pandemic Cohort Network (NAPKON)
Appel K, Nürnberger C, Bahmer T, Förster C, Polidori M, Kohls M, Kraus T, Hettich-Damm N, Petersen J, Blaschke S, Bröhl I, Butzmann J, Dashti H, Deckert J, Dreher M, Fiedler K, Finke C, Geisler R, Hanses F, Hopff S, Jensen B, Konik M, Lehnert K, de Miranda S, Mitrov L, Miljukov O, Reese J, Rohde G, Scherer M, Tausche K, Tebbe J, Vehreschild J, Voit F, Wagner P, Weigl M, Lemhöfer C
INFECTION. 2024;52(5):1813-1829.

Prevalence of infectious diseases, immunity to vaccine-preventable diseases and chronic medical conditions among Ukrainian refugees in Germany - A cross sectional study from the German Network University Medicine (NUM)
Brinkmann F, Friedrichs A, Behrens G, Behrens P, Berner R, Caliebe A, Denkinger C, Giesbrecht K, Gussew A, Hoffmann A, Hojenski L, Hovardovska O, Dopfer-Jablonka A, Kaasch A, Kobbe R, Kraus M, Lindner A, Maier C, Mitrov L, Nauck M, de Miranda S, Scherer M, Schmiedel Y, Stahl D, Timmesfeld N, Toepfner N, Vehreschild J, Wohlgemuth W, Petersmann A, Vehreschild M
J INFECT PUBLIC HEAL. 2024;17(4):642-649.

Epidemiology of 7375 children and adolescents hospitalized with COVID-19 in Germany, reported via a prospective, nationwide surveillance study in 2020-2022
Doenhardt M, Hufnagel M, Diffloth N, Hübner J, Mauer R, Schneider D, Simon A, Tenenbaum T, Trotter A, Armann J, Berner R
SCI REP-UK. 2024;14(1):47.

Health and socio-demographic background of Ukrainian minors and their families in Germany - challenges for refugee medicine: A cross-sectional study from the German Network University Medicine (NUM)
Hoffmann A, Kobbe R, Denz R, Maier C, Toepfner N, Timmesfeld N, Petersmann A, Giesbrecht K, Hovardovska O, Vehreschild J, Scherer M, de Miranda S, Mitrov L, Friedrichs A, Caliebe A, Skipiol K, Holzwarth S, Kaur Y, Schlegtendal A, Hojenski L, Ruß A, Vehreschild M, Brinkmann F
EUR J PEDIATR. 2024;184(1):64.

Delayed Induction of Noninflammatory SARS-CoV-2 Spike-Specific IgG4 Antibodies Detected 1 Year After BNT162b2 Vaccination in Children
Kobbe R, Rau C, Schulze-Sturm U, Stahl F, Fonseca-Brito L, Diemert A, Lütgehetmann M, Addo M, Arck P, Weskamm L
PEDIATR INFECT DIS J. 2024;43(12):1200-1203.

Implementation of Recommendations on the Use of Corticosteroids in Severe COVID-19
Camirand-Lemyre F, Merson L, Tirupakuzhi Vijayaraghavan B, Burrell A, Citarella B, Domingue M, Lévesque S, Usuf E, Wils E, Ohshimo S, Martin-Loeches I, Sandulescu O, Laake J, Lamontagne F
JAMA NETW OPEN. 2023;6(12):e2346502.

Neurological manifestations of COVID-19 in adults and children
Cho S, White N, Premraj L, Battaglini D, Fanning J, Suen J, Bassi G, Fraser J, Robba C, Griffee M, Singh B, Citarella B, Merson L, Solomon T, Thomson D
BRAIN. 2023;146(4):1648-1661.

Long-Term Antibody Response to SARS-CoV-2 in Children
Dunay G, Barroso M, Woidy M, Danecka M, Engels G, Hermann K, Neumann F, Paul K, Beime J, Escherich G, Fehse K, Grinstein L, Haniel F, Haupt L, Hecher L, Kehl T, Kemen C, Kemper M, Kobbe R, Kohl A, Klokow T, Nörz D, Olfe J, Schlenker F, Schmiesing J, Schrum J, Sibbertsen F, Stock P, Tiede S, Vettorazzi E, Zazara D, Zapf A, Lütgehetmann M, Oh J, Mir T, Muntau A, Gersting S
J CLIN IMMUNOL. 2023;43(1):46-56.

Partially Reversible Immunodeficiency After In-Utero Exposure to Immunosuppressants
Gossling K, Kobbe R, Boetticher B, Soura S, Borkhardt A, Wittkowski H, Schwab M, Kobbe G, Neubert J, Ghosh S, Laws H, Oommen P
DTSCH ARZTEBL INT. 2023;120(46):795-796.

Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19
Kartsonaki C, Baillie J, Barrio N, Baruch J, Beane A, Blumberg L, Bozza F, Broadley T, Burrell A, Carson G, Citarella B, Dagens A, Dankwa E, Donnelly C, Dunning J, Elotmani L, Escher M, Farshait N, Goffard J, Gonçalves B, Hall M, Hashmi M, Sim Lim Heng B, Ho A, Jassat W, Pedrera Jiménez M, Laouenan C, Lissauer S, Martin-Loeches I, Mentré F, Merson L, Morton B, Munblit D, Nekliudov N, Nichol A, Singh Oinam B, Ong D, Panda P, Petrovic M, Pritchard M, Ramakrishnan N, Ramos G, Roger C, Sandulescu O, Semple M, Sharma P, Sigfrid L, Somers E, Streinu-Cercel A, Taccone F, Vecham P, Kumar Tirupakuzhi Vijayaraghavan B, Wei J, Wils E, Ci Wong X, Horby P, Rojek A, Olliaro P
INT J EPIDEMIOL. 2023;52(2):355-376.

Reduced Humoral and Cellular Immune Response to Primary COVID-19 mRNA Vaccination in Kidney Transplanted Children Aged 5–11 Years
Lalia J, Schild R, Lütgehetmann M, Dunay G, Kallinich T, Kobbe R, Massoud M, Oh J, Pietzsch L, Schulze-Sturm U, Schuetz C, Sibbertsen F, Speth F, Thieme S, Witkowski M, Berner R, Muntau A, Gersting S, Toepfner N, Pagel J, Paul K
VIRUSES-BASEL. 2023;15(7):1553.

Treatment of Infants and Children With SARS-CoV-2 Monoclonal Antibodies: A European Case Series
Rau C, Auer-Hackenberg L, Deubzer H, Schwabel E, Jaros M, Diederichs A, Lehrnbecher T, Holm M, von Linstow M, Martin L, Dinges S, Rothensteiner M, Siepermann M, Strenger V, von Both U, Teig N, Brinkmann F, Leeb F, Zeitlinger M, Kobbe R, Götzinger F
PEDIATR INFECT DIS J. 2023;42(2):125-129.

Correction to: Functional Relevance of CTLA4 Variants: an Upgraded Approach to Assess CTLA4‑Dependent Transendocytosis by Flow Cytometry
Rojas-Restrepo J, Sindram E, Zenke S, Haberstroh H, Mitsuiki N, Gabrysch A, Huebscher K, Posadas-Cantera S, Krausz M, Kobbe R, Rohr J, Grimbacher B, Gamez-Diaz L
J CLIN IMMUNOL. 2023;43(8):2090.

Functional Relevance of CTLA4 Variants: an Upgraded Approach to Assess CTLA4-Dependent Transendocytosis by Flow Cytometry
Rojas-Restrepo J, Sindram E, Zenke S, Haberstroh H, Mitsuiki N, Gabrysch A, Huebscher K, Posadas-Cantera S, Krausz M, Kobbe R, Rohr J, Grimbacher B, Gámez-Díaz L
J CLIN IMMUNOL. 2023;43(8):2076-2089.

Validation of extracorporeal membrane oxygenation mortality prediction and severity of illness scores in an international COVID-19 cohort
Shah N, Xue B, Xu Z, Yang H, Marwali E, Dalton H, Payne P, Lu C, Said A
ARTIF ORGANS. 2023;47(9):1490-1502.

Neuropsychiatric manifestations and sleep disturbances with dolutegravir-based antiretroviral therapy versus standard of care in children and adolescents: a secondary analysis of the ODYSSEY trial
Turkova A, White E, Kekitiinwa A, Mumbiro V, Kaudha E, Liberty A, Ahimbisibwe G, Moloantoa T, Srirompotong U, Mosia N, Puthanakit T, Kobbe R, Fortuny C, Kataike H, Bbuye D, Na-Rajsima S, Coelho A, Lugemwa A, Bwakura-Dangarembizi M, Klein N, Mujuru H, Kityo C, Cotton M, Ferrand R, Giaquinto C, Rojo P, Violari A, Gibb D, Ford D
LANCET CHILD ADOLESC. 2023;7(10):718-727.

Once-daily dolutegravir-based antiretroviral therapy in infants and children living with HIV from age 4 weeks: results from the below 14 kg cohort in the randomised ODYSSEY trial
Amuge P, Lugemwa A, Wynne B, Mujuru H, Violari A, Kityo C, Archary M, Variava E, White E, Turner R, Shakeshaft C, Ali S, Nathoo K, Atwine L, Liberty A, Bbuye D, Kaudha E, Mngqibisa R, Mosala M, Mumbiro V, Nanduudu A, Ankunda R, Maseko L, Kekitiinwa A, Giaquinto C, Rojo P, Gibb D, Turkova A, Ford D
LANCET HIV. 2022;9(9):e638-e648.

Recommendations regarding screening, diagnosis, treatment, and clinical management of Chagas disease in Germany: AWMF-Register-Nr. 042-009
Bissinger A, Deneke T, Feldt T, Froeschl G, Gálvez R, Guertler L, Hoerauf A, Hübner M, Jacobs T, Jochum J, Kobbe R, Leuschner F, Pritsch M, Ramharter M, Richter J, Rieke B, Schmiedel S, Seeba H, Stich A, Strauss R, Weinauer F, Weizsäcker K, Wirth M, Zoller T
2022.

Mucha-Habermann disease: a pediatric case report and proposal of a risk score
Blohm M, Ebenebe C, Rau C, Escherich C, Johannsen J, Escherich G, Driemeyer J, Nagel P, Kobbe R, Lütgehetmann M, Lennartz M, Booken N, Schneider S, Singer D
INT J DERMATOL. 2022;61(4):401-409.

Clinical efficacy and in vitro neutralization capacity of monoclonal antibodies for severe acute respiratory syndrome coronavirus 2 delta and omicron variants
Brehm T, Pfefferle S, von Possel R, Karolyi M, Zoufaly A, Wichmann D, Kobbe R, Emmerich P, Nörz D, Aepfelbacher M, Schulze Zur Wiesch J, Addo M, Schmiedel S, Lütgehetmann M
J MED VIROL. 2022;94(10):5038-5043.

Therapeutic options for CTLA-4 Insufficiency
Egg D, Rump I, Mitsuiki N, Rojas-Restrepo J, Maccari M, Schwab C, Gabrysch A, Warnatz K, Goldacker S, Patiño V, Wolff D, Okada S, Hayakawa S, Shikama Y, Kanda K, Imai K, Sotomatsu M, Kuwashima M, Kamiya T, Morio T, Matsumoto K, Mori T, Yoshimoto Y, Dybedal I, Kanariou M, Kucuk Z, Chapdelaine H, Petruzelkova L, Lorenz H, Sullivan K, Heimall J, Moutschen M, Litzman J, Recher M, Albert M, Hauck F, Seneviratne S, Schmid J, Kolios A, Unglik G, Klemann C, Snapper S, Giulino-Roth L, Svaton M, Platt C, Hambleton S, Neth O, Gosse G, Reinsch S, Holzinger D, Kim Y, Bakhtiar S, Atschekzei F, Schmidt R, Sogkas G, Chandrakasan S, Rae W, Derfalvi B, Marquart H, Ozen A, Kiykim A, Karakoc-Aydiner E, Králíčková P, de Bree G, Kiritsi D, Seidel M, Kobbe R, Dantzer J, Alsina L, Armangue T, Lougaris V, Agyeman P, Nyström S, Buchbinder D, Arkwright P, Grimbacher B
J ALLERGY CLIN IMMUN. 2022;149(2):736-746.

Detrimental NFKB1 missense variants affecting the Rel-homology domain of p105/p50
Fliegauf M, Kinnunen M, Posadas-Cantera S, Camacho-Ordonez N, Abolhassani H, Alsina L, Atschekzei F, Bogaert D, Burns S, Church J, Dückers G, Freeman A, Hammarström L, Hanitsch L, Kerre T, Kobbe R, Sharapova S, Siepermann K, Speckmann C, Steiner S, Verma N, Walter J, Westermann-Clark E, Goldacker S, Warnatz K, Varjosalo M, Grimbacher B
FRONT IMMUNOL. 2022;13:.

ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19
Garcia-Gallo E, Merson L, Kennon K, Kelly S, Citarella B, Fryer D, Shrapnel S, Lee J, Duque S, Fuentes Y, Balan V, Smith S, Wei J, Gonçalves B, Russell C, Sigfrid L, Dagens A, Olliaro P, Baruch J, Kartsonaki C, Dunning J, Rojek A, Rashan A, Beane A, Murthy S, Reyes L
SCI DATA. 2022;9(1):454.

An international observational study to assess the impact of the Omicron variant emergence on the clinical epidemiology of COVID-19 in hospitalised patients
Gonçalves B, Hall M, Jassat W, Balan V, Murthy S, Kartsonaki C, Semple M, Rojek A, Baruch J, Reyes L, Dasgupta A, Dunning J, Citarella B, Pritchard M, Martín-Quiros A, Sili U, Baillie J, Aryal D, Arabi Y, Rashan A, Angheben A, Caoili J, Carrier F, Harrison E, Gómez-Junyent J, Figueiredo-Mello C, Douglas J, Mat Nor M, Chow Y, Wong X, Bertagnolio S, Thwin S, Streinu-Cercel A, Salazar L, Rishu A, Rangappa R, Ong D, Hashmi M, Carson G, Diaz J, Fowler R, Kraemer M, Wils E, Horby P, Merson L, Olliaro P
ELIFE. 2022;11:.

Vertical anti-SARS-CoV-2 monoclonal antibody transfer from mothers to HIV-exposed and unexposed infants
Kobbe R, Schulze-Sturm U, Kurnaz P, Rau C, Tallarek A, Lütgehetmann M, Jordan S, Schmiedel S
AIDS. 2022;36(11):1613-1615.

Statistical biases due to anonymization evaluated in an open clinical dataset from COVID-19 patients
Koll C, Hopff S, Meurers T, Lee C, Kohls M, Stellbrink C, Thibeault C, Reinke L, Steinbrecher S, Schreiber S, Mitrov L, Frank S, Miljukov O, Erber J, Hellmuth J, Reese J, Steinbeis F, Bahmer T, Hagen M, Meybohm P, Hansch S, Vadász I, Krist L, Jiru-Hillmann S, Prasser F, Vehreschild J
SCI DATA. 2022;9(1):.

Paediatric COVID-19 mortality: a database analysis of the impact of health resource disparity
Marwali E, Kekalih A, Yuliarto S, Wati D, Rayhan M, Valerie I, Cho H, Jassat W, Blumberg L, Masha M, Semple C, Swann O, Kohns Vasconcelos M, Popielska J, Murthy S, Fowler R, Guerguerian A, Streinu-Cercel A, Pathmanathan M, Rojek A, Kartsonaki C, Gonçalves B, Citarella B, Merson L, Olliaro P, Dalton H
BMJ PAEDIATR OPEN. 2022;6(1):.

Fatal outcome of SARS-CoV-2 infection (B1.1.7) in a 4-year-old child
Menger J, Apostolidou S, Edler C, Kniep I, Kobbe R, Singer D, Sperhake J
INT J LEGAL MED. 2022;136(1):189-192.

Aktualisierte Empfehlungen zur infektiologischen Versorgung von Flüchtlingen im Kindes- und Jugendalter in Deutschland (Stand 30. März 2022), angemeldet als S1-Leitlinie (AWMF-Register Nr. 048-017): Stellungnahme der Deutschen Gesellschaft für Pädiatrische Infektiologie e. V. (DGPI), der Gesellschaft für Tropenpädiatrie und Internationale Kindergesundheit e. V. (GTP), des Berufsverbandes der Kinder- und Jugendärzte e. V. (BVKJ) und der Deutschen Gesellschaft für Kinder- und Jugendmedizin e. V. (DGKJ), unter Mitarbeit des Berufsverbands der Ärztinnen und Ärzte des Öffentlichen Gesundheitsdienstes e. V. (BVÖGD), der Deutschen Gesellschaft für Kinderchirurgie e. V. (DGKCH), der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe e. V. (DGGG), Deutsche Gesellschaft für Allgemeinmedizin und Familienmedizin (DEGAM), des Bündnis Kinder- und Jugendgesundheit e. V. (früher Deutsche Akademie für Kinder- und Jugendmedizin, DAKJ), der Deutschen Gesellschaft für Tropenmedizin, Reisemedizin und Globale Gesundheit e. V. (DTG), der Deutschen Gesellschaft für Globale und Tropenchirurgie e. V. (DTC) und der Pädiatrisch Infektiologischen Gruppe Schweiz (PIGS)
Pfeil J, Assaad K, von Both U, Janda A, Kitz C, Kobbe R, Kunze M, Lindert J, Ritz N, Trapp S, Hufnagel M
MONATSSCHR KINDERH. 2022;170(7):632-647.

Data quality of reported child immunization coverage in 194 countries between 2000 and 2019.
Rau C, Lüdecke D, Dumolard L, Grevendonk J, Wiernik B, Kobbe R, Gacic-Dobo M, Danovaro-Holliday M
PLOS Global Public Health. 2022;2(2):e0000140.

Respiratory support in patients with severe COVID-19 in the International Severe Acute Respiratory and Emerging Infection (ISARIC) COVID-19 study: a prospective, multinational, observational study
Reyes L, Murthy S, Garcia-Gallo E, Merson L, Ibáñez-Prada E, Rello J, Fuentes Y, Martin-Loeches I, Bozza F, Duque S, Taccone F, Fowler R, Kartsonaki C, Gonçalves B, Citarella B, Aryal D, Burhan E, Cummings M, Delmas C, Diaz R, Figueiredo-Mello C, Hashmi M, Panda P, Jiménez M, Rincon D, Thomson D, Nichol A, Marshall J, Olliaro P
CRIT CARE. 2022;26(1):276.

A Multi‑Center, Open‑Label, Single‑Arm Trial to Evaluate the Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary Immunodeficiency
Santamaria M, Neth O, Douglass J, Krivan G, Kobbe R, Bernatowska E, Grigoriadou S, Bethune C, Chandra A, Horneff G, Borte M, Sonnenschein A, Kralickova P, Ramón S, Langguth D, Gonzalez-Granado L, Alsina L, Querolt M, Griffin R, Hames C, Mondou E, Price J, Sanz A, Lin J
J CLIN IMMUNOL. 2022;42(3):500-511.

Correction to: A Multi-center, Open-Label, Single-Arm Trial to Evaluate the Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary Immunodeficiency
Santamaria M, Neth O, Douglass J, Krivan G, Kobbe R, Bernatowska E, Grigoriadou S, Bethune C, Chandra A, Horneff G, Borte M, Sonnenschein A, Kralickova P, Ramón S, Langguth D, Gonzalez-Granado L, Alsina L, Querolt M, Griffin R, Hames C, Mondou E, Price J, Sanz A, Lin J
J CLIN IMMUNOL. 2022;42(3):512-513.

Therapeutic Management of COVID-19 in a Pediatric Patient with Neurodegenerative CLN2 Disease and ICV-Enzyme Replacement Therapy: A Case Report
Schwering C, Apostolidou S, Deindl P, Christner M, Knobloch J, Herrmann J, Kobbe R, Schulz A, Singer D, Ebenebe C
NEUROPEDIATRICS. 2022;53(5):381-384.

Infektiologische Versorgung minderjähriger Flüchtlinge am Beispiel der Ukraine: Vorgehen in Deutschland gemäß der S1-Leitlinine (AWMF-Register Nr. 048-017)
Spielberger B, Pfeil J, Assaad K, von Both U, Janda A, Kitz C, Kobbe R, Kunze M, Lindert J, Ritz N, Trapp S, Hufnagel M
MONATSSCHR KINDERH. 2022;170(12):1103-1112.

Einheitliche Basisversorgung von Kindern und Jugendlichen mit Long COVID: Stellungnahme einer multidisziplinären Arbeitsgruppe der DGKJ-Konvent-Gesellschaften (Stand: Februar 2022)
Töpfner N, Alberer M, Ankermann T, Bender S, Berner R, de Laffolie J, Dingemann J, Heinicke D, Haas J, Hufnagel M, Hummel T, Huppertz H, Knuf M, Kobbe R, Lücke T, Riedel J, Rosenecker J, Wölfle J, Schneider B, Schneider D, Schriever V, Schroeder A, Stojanov S, Tenenbaum T, Trapp S, Vilser D, Brinkmann F, Behrends U
MONATSSCHR KINDERH. 2022;170(6):539-547.

Dolutegravir twice-daily dosing in children with HIV-associated tuberculosis: a pharmacokinetic and safety study within the open-label, multicentre, randomised, non-inferiority ODYSSEY trial
Turkova A, Waalewijn H, Chan M, Bollen P, Bwakura-Dangarembizi M, Kekitiinwa A, Cotton M, Lugemwa A, Variava E, Ahimbisibwe G, Srirompotong U, Mumbiro V, Amuge P, Zuidewind P, Ali S, Kityo C, Archary M, Ferrand R, Violari A, Gibb D, Burger D, Ford D, Colbers A
LANCET HIV. 2022;9(9):E627-E637.

COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study

INFECTION. 2021;49(5):889-905.

The value of open-source clinical science in pandemic response: lessons from ISARIC

LANCET INFECT DIS. 2021;21(12):1623-1624.

Fatal COVID-19 in a Child with Persistence of SARS-CoV-2 Despite Extensive Multidisciplinary Treatment: A Case Report
Apostolidou S, Harbauer T, Lasch P, Biermann D, Hempel M, Lütgehetmann M, Pfefferle S, Herrmann J, Rüffer A, Reinshagen K, Kozlik-Feldmann R, Gieras A, Kniep I, Oh J, Singer D, Ebenebe C, Kobbe R
CHILDREN-BASEL. 2021;8(7):.

SARS-CoV-2 Reinfection in a Healthcare Worker Despite the Presence of Detectable Neutralizing Antibodies
Brehm T, Pfefferle S, von Possel R, Kobbe R, Nörz D, Schmiedel S, Grundhoff A, Olearo F, Emmerich P, Robitaille A, Günther T, Braun P, Andersen G, Knobloch J, Addo M, Lohse A, Aepfelbacher M, Fischer N, Schulze Zur Wiesch J, Lütgehetmann M
VIRUSES-BASEL. 2021;13(4):.

Phylogenomics of Mycobacterium africanum reveals a new lineage and a complex evolutionary history
Coscolla M, Gagneux S, Menardo F, Loiseau C, Ruiz-Rodriguez P, Borrell S, Otchere I, Asante-Poku A, Asare P, Sánchez-Busó L, Gehre F, Sanoussi C, Antonio M, Affolabi D, Fyfe J, Beckert P, Niemann S, Alabi A, Grobusch M, Kobbe R, Parkhill J, Beisel C, Fenner L, Böttger E, Meehan C, Harris S, de Jong B, Yeboah-Manu D, Brites D
MICROB GENOMICS. 2021;7(2):.

Genetic Analysis of a Cohort of 275 Patients with Hyper-IgE Syndromes and/or Chronic Mucocutaneous Candidiasis
Frede N, Rojas-Restrepo J, Caballero Garcia de Oteyza A, Buchta M, Hübscher K, Gámez-Díaz L, Proietti M, Saghafi S, Chavoshzadeh Z, Soler-Palacin P, Galal N, Adeli M, Aldave-Becerra J, Al-Ddafari M, Ardenyz Ö, Atkinson T, Kut F, Çelmeli F, Rees H, Kilic S, Kirovski I, Klein C, Kobbe R, Korganow A, Lilic D, Lunt P, Makwana N, Metin A, Özgür T, Karakas A, Seneviratne S, Sherkat R, Sousa A, Unal E, Patiroglu T, Wahn V, von Bernuth H, Whiteford M, Doffinger R, Jouhadi Z, Grimbacher B
J CLIN IMMUNOL. 2021;41(8):1804-1838.

Ten months of temporal variation in the clinical journey of hospitalised patients with COVID-19: An observational cohort
Hall M, Baruch J, Carson G, Citarella B, Dagens A, Dankwa E, Donnelly C, Dunning J, Escher M, Kartsonaki C, Merson L, Pritchard M, Wei J, Horby P, Rojek A, Olliaro P
ELIFE. 2021;10:.

Longitudinal development of antibody responses in covid-19 patients of different severity with elisa, peptide, and glycan arrays: An immunological case series
Heidepriem J, Dahlke C, Kobbe R, Santer R, Koch T, Fathi A, Seco B, Ly M, Schmiedel S, Schwinge D, Serna S, Sellrie K, Reichardt N, Seeberger P, Addo M, Loeffler F
PATHOGENS. 2021;10(4):.

Leitlinie: Diagnostik und Therapie der Malaria: AWMF Register-Nr. 042-001
Kreuels B, Bissinger A, Boecken G, Burchard G, Feldt T, Grobusch M, Jochum J, Kroidl I, Löbermann M, Löscher T, Rothe C, Schmiedel S, Schneitler S, Steiner F, Stich A, Stojkovic M, Wiemer D, Belard S, Kurth F, Tannich E, Kobbe R, Wichmann D, Ramharter M
2021.

A distinct CD38+CD45RA+ population of CD4+, CD8+, and double-negative T cells is controlled by FAS
Maccari M, Fuchs S, Kury P, Andrieux G, Völkl S, Bengsch B, Lorenz M, Heeg M, Rohr J, Jägle S, Castro C, Groß M, Warthorst U, König C, Fuchs I, Speckmann C, Thalhammer J, Kapp F, Seidel M, Dückers G, Schönberger S, Schütz C, Führer M, Kobbe R, Holzinger D, Klemann C, Smisek P, Owens S, Horneff G, Kolb R, Naumann-Bartsch N, Miano M, Staniek J, Rizzi M, Kalina T, Schneider P, Erxleben A, Backofen R, Ekici A, Niemeyer C, Warnatz K, Grimbacher B, Eibel H, Mackensen A, Frei A, Schwarz K, Boerries M, Ehl S, Rensing-Ehl A
J EXP MED. 2021;218(2):e20192191.

ODYSSEY clinical trial design: a randomised global study to evaluate the efficacy and safety of dolutegravir-based antiretroviral therapy in HIV-positive children, with nested pharmacokinetic sub-studies to evaluate pragmatic WHO-weight-band based dolutegravir dosing
Moore C, Turkova A, Mujuru H, Kekitiinwa A, Lugemwa A, Kityo C, Barlow-Mosha L, Cressey T, Violari A, Variava E, Cotton M, Archary M, Compagnucci A, Puthanakit T, Behuhuma O, Saϊdi Y, Hakim J, Amuge P, Atwine L, Musiime V, Burger D, Shakeshaft C, Giaquinto C, Rojo P, Gibb D, Ford D, , Kobbe R
BMC INFECT DIS. 2021;21(1):5.

SARS Coronavirus-2 variant tracing within the first Coronavirus Disease 19 clusters in northern Germany
Pfefferle S, Günther T, Kobbe R, Czech-Sioli M, Nörz D, Santer R, Oh J, Kluge S, Oestereich L, Peldschus K, Indenbirken D, Huang J, Grundhoff A, Aepfelbacher M, Knobloch J, Lütgehetmann M, Fischer N
CLIN MICROBIOL INFEC. 2021;27(1):130.e5-130.e8.

Remdesivir, Sinus Bradycardia and Therapeutic Drug Monitoring in Children With Severe COVID-19
Rau C, Apostolidou S, Singer D, Avataneo V, Kobbe R
PEDIATR INFECT DIS J. 2021;40(12):e528-e529.

Establishing the Molecular Diagnoses in a Cohort of 291 Patients With Predominantly Antibody Deficiency by Targeted Next-Generation Sequencing: Experience From a Monocentric Study
Rojas-Restrepo J, Caballero-Oteyza A, Huebscher K, Haberstroh H, Fliegauf M, Keller B, Kobbe R, Warnatz K, Ehl S, Proietti M, Grimbacher B
FRONT IMMUNOL. 2021;12:.

Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations
Thalhammer J, Kindle G, Nieters A, Rusch S, Seppänen M, Fischer A, Grimbacher B, Edgar D, Buckland M, Mahlaoui N, Ehl S
J ALLERGY CLIN IMMUN. 2021;148(5):1332-1341.e5.

Dolutegravir as First- or Second-Line Treatment for HIV-1 Infection in Children
Turkova A, White E, Mujuru H, Kekitiinwa A, Kityo C, Violari A, Lugemwa A, Cressey T, Musoke P, Variava E, Cotton M, Archary M, Puthanakit T, Behuhuma O, Kobbe R, Welch S, Bwakura-Dangarembizi M, Amuge P, Kaudha E, Barlow-Mosha L, Makumbi S, Ramsagar N, Ngampiyaskul C, Musoro G, Atwine L, Liberty A, Musiime V, Bbuye D, Ahimbisibwe G, Chalermpantmetagul S, Ali S, Sarfati T, Wynne B, Shakeshaft C, Colbers A, Klein N, Bernays S, Saïdi Y, Coelho A, Grossele T, Compagnucci A, Giaquinto C, Rojo P, Ford D, Gibb D
NEW ENGL J MED. 2021;385(27):2531-2543.

Distinct early IgA profile may determine severity of COVID-19 symptoms: an immunological case series
Dahlke C, Heidepriem J, Kobbe R, Santer R, Koch T, Fathi A, Ly M, Schmiedel S, Seeberger P, , Addo M, Loeffler F
medRxiv. 2020.

COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study
Götzinger F, Santiago-García B, Noguera-Julián A, Lanaspa M, Lancella L, Calò Carducci F, Gabrovska N, Velizarova S, Prunk P, Osterman V, Krivec U, Lo Vecchio A, Shingadia D, Soriano-Arandes A, Melendo S, Lanari M, Pierantoni L, Wagner N, L'Huillier A, Heininger U, Ritz N, Bandi S, Krajcar N, Roglić S, Santos M, Christiaens C, Creuven M, Buonsenso D, Welch S, Bogyi M, Brinkmann F, Tebruegge M, , Kobbe R, Rau C
LANCET CHILD ADOLESC. 2020;4(9):653-661.

Medizinische Mikrobiologie und Infektiologie S. Suerbaum, G.D. Burchard, S.H.E. Kaufmann, T.F. Schulz: Infektionen bei Immunsuppression, Infektionen bei primären Immundefekten, Opportunistische Infektionen bei Patienten mit HIV-Infektion, Infektionen bei Organtransplantation, Infektionen nach hämatopoetischer Stammzelltransplantation, Infektionen bei Asplenie, Infektionen bei medikamentös induzierter Immunsuppression
Kobbe R
2020.

Characterization of the clinical and immunologic phenotype and management of 157 individuals with 56 distinct heterozygous NFKB1 mutations
Lorenzini T, Fliegauf M, Klammer N, Frede N, Proietti M, Bulashevska A, Camacho-Ordonez N, Varjosalo M, Kinnunen M, de Vries E, van der Meer J, Ameratunga R, Roifman C, Schejter Y, Kobbe R, Hautala T, Atschekzei F, Schmidt R, Schröder C, Stepensky P, Shadur B, Pedroza L, van der Flier M, Martínez-Gallo M, Gonzalez-Granado L, Allende L, Shcherbina A, Kuzmenko N, Zakharova V, Neves J, Svec P, Fischer U, Ip W, Bartsch O, Barış S, Klein C, Geha R, Chou J, Alosaimi M, Weintraub L, Boztug K, Hirschmugl T, Dos Santos Vilela M, Holzinger D, Seidl M, Lougaris V, Plebani A, Alsina L, Piquer-Gibert M, Deyà-Martínez A, Slade C, Aghamohammadi A, Abolhassani H, Hammarström L, Kuismin O, Helminen M, Allen H, Thaventhiran J, Freeman A, Cook M, Bakhtiar S, Christiansen M, Cunningham-Rundles C, Patel N, Rae W, Niehues T, Brauer N, Syrjänen J, Seppänen M, Burns S, Tuijnenburg P, Kuijpers T, Warnatz K, Grimbacher B
J ALLERGY CLIN IMMUN. 2020;146(4):901-911.

Prevalence and Clinical Outcomes of Poor Immune Response Despite Virologically Suppressive Antiretroviral Therapy Among Children and Adolescents With Human Immunodeficiency Virus in Europe and Thailand: Cohort Study
Smith C, Marques L, Klein N, Gullen S, Judd A, Thorne C, Goodall R, Koenigs C, Spoulou V, Prata F, Goetghebuer T, Chiappini E, Galli L, Naver L, Giaquinto C, Gibb D, Marczynska M, Okhonskaia L, Klimkait T, Lallernant M, Ngo-Giang-Huong N, Kiseleva G, Malyuta R, Volokha A
CLIN INFECT DIS. 2020;70(3):404-415.

Successful Immunochemotherapy for Burkitt Lymphoma During Pregnancy as a Bridge to Postpartum High-Dose Methotrexate Therapy: A Case Report and Review of the Literature
Stang A, Schwärzler P, Schmidtke S, Tolosa E, Kobbe R
CL LYMPH MYELOM LEUK. 2020;20(6):e284-e290.

Intravenous Artesunate for Imported Severe Malaria in Children Treated in Four Tertiary Care Centers in Germany: A Retrospective Study
Bélard S, Brand J, Schulze-Sturm U, Janda A, von Both U, Tacoli C, Alberer M, Kempf C, Stegemann M, Krüger R, Varnholt V, Blohm M, Reiter K, Zoller T, Suttorp N, Mall M, von Bernuth H, Gratopp A, Hübner J, Hufnagel M, Kobbe R, Kurth F
PEDIATR INFECT DIS J. 2019;38(11):e295-e300.

The German National Registry of Primary Immunodeficiencies (2012-2017)
El-Helou S, Biegner A, Bode S, Ehl S, Heeg M, Maccari M, Ritterbusch H, Speckmann C, Rusch S, Scheible R, Warnatz K, Atschekzei F, Beider R, Ernst D, Gerschmann S, Jablonka A, Mielke G, Schmidt R, Schürmann G, Sogkas G, Baumann U, Klemann C, Viemann D, von Bernuth H, Krüger R, Hanitsch L, Scheibenbogen C, Wittke K, Albert M, Eichinger A, Hauck F, Klein C, Rack-Hoch A, Sollinger F, Avila A, Borte M, Borte S, Fasshauer M, Hauenherm A, Kellner N, Müller A, Ülzen A, Bader P, Bakhtiar S, Lee J, Heß U, Schubert R, Wölke S, Zielen S, Ghosh S, Laws H, Neubert J, Oommen P, Hönig M, Schulz A, Steinmann S, Schwarz K, Dückers G, Lamers B, Langemeyer V, Niehues T, Shai S, Graf D, Müglich C, Schmalzing M, Schwaneck E, Tony H, Dirks J, Haase G, Liese J, Morbach H, Foell D, Hellige A, Wittkowski H, Masjosthusmann K, Geberzahn L, Hedrich C, Müller C, Rösen-Wolff A, Roesler J, Zimmermann A, Behrends U, Rieber N, Schauer U, Handgretinger R, Holzer U, Henes J, Kanz L, Boesecke C, Rockstroh J, Schwarze-Zander C, Wasmuth J, Dilloo D, Hülsmann B, Schönberger S, Schreiber S, Zeuner R, Ankermann T, von Bismarck P, Huppertz H, Kaiser-Labusch P, Greil J, Jakoby D, Kulozik A, Metzler M, Naumann-Bartsch N, Sobik B, Graf N, Heine S, Kobbe R, Lehmberg K, Müller I, Herrmann F, Horneff G, Klein A, Peitz J, Schmidt N, Bielack S, Groß-Wieltsch U, Classen C, Klasen J, Deutz P, Kamitz D, Lassay L, Tenbrock K, Wagner N, Bernbeck B, Brummel B, Lara-Villacanas E, Münstermann E, Schneider D, Tietsch N, Westkemper M, Weiß M, Kramm C, Kühnle I, Kullmann S, Girschick H, Specker C, Vinnemeier-Laubenthal E, Haenicke H, Schweigerer L, Müller T, Stiefel M, Belohradsky B, Soetedjo V, Kindle G, Grimbacher B
FRONT IMMUNOL. 2019;10:1272.

Clinical and Immunological Phenotype of Patients With Primary Immunodeficiency Due to Damaging Mutations in NFKB2
Klemann C, Camacho-Ordonez N, Yang L, Eskandarian Z, Rojas-Restrepo J, Frede N, Bulashevska A, Heeg M, Al-Ddafari M, Premm J, Seidl M, Ammann S, Sherkat R, Radhakrishnan N, Warnatz K, Unger S, Kobbe R, Hüfner A, Leahy T, Ip W, Burns S, Fliegauf M, Grimbacher B
FRONT IMMUNOL. 2019;10:297.

Reducing Hematologic Toxicity With Short Course Postexposure Prophylaxis With Zidovudine for HIV-1 Exposed Infants With Low Transmission Risk
Nguyen T, Kobbe R, Schulze-Sturm U, Blohm M, Hollwitz B, Hertling S, Becker C, Oommen P, Laws H, Martignoni F, Ole Jensen B, Olah K, Schmidtke S, Kreuels B, Vasconcelos M, Neubert J
PEDIATR INFECT DIS J. 2019;38(7):727-730.

Impact of refugee influx on the epidemiology of late-presenting HIV-infected pregnant women and mother-to-child transmission: comparing a southern and northern medical centre in Germany
Singer K, Schulze-Sturm U, Alba-Alejandre I, Hollwitz B, Nguyen T, Sollinger F, Eberle J, Hübner J, Kobbe R, Genzel-Boroviczény O, von Both U
INFECTION. 2019;47(5):847-852.

Malaria in Eritrean migrants newly arrived in seven European countries, 2011 to 2016
Sondén K, Rolling T, Wångdahl A, Ydring E, Vygen-Bonnet S, Kobbe R, Douhan J, Hammar U, Duijster J, de Gier B, Freedman J, Gysin N, Stark K, Stevens F, Vestergaard L, Tegnell A, Färnert A
EUROSURVEILLANCE. 2019;24(5):.

BCL11B mutations in patients affected by a neurodevelopmental disorder with reduced type 2 innate lymphoid cells
Lessel D, Gehbauer C, Bramswig N, Schluth-Bolard C, Venkataramanappa S, van Gassen K, Hempel M, Haack T, Baresic A, Genetti C, Funari M, Lessel I, Kuhlmann L, Simon R, Liu P, Denecke J, Kuechler A, de Kruijff I, Shoukier M, Lek M, Mullen T, Lüdecke H, Lerario A, Kobbe R, Krieger T, Demeer B, Lebrun M, Keren B, Nava C, Buratti J, Afenjar A, Shinawi M, Guillen Sacoto M, Gauthier J, Hamdan F, Laberge A, Campeau P, Louie R, Cathey S, Prinz I, Jorge A, Terhal P, Lenhard B, Wieczorek D, Strom T, Agrawal P, Britsch S, Tolosa E, Kubisch C
BRAIN. 2018;141(8):2299-2311.

Universal screening for latent and active tuberculosis (TB) in asylum seeking children, Bochum and Hamburg, Germany, September 2015 to November 2016
Mueller-Hermelink M, Kobbe R, Methling B, Rau C, Schulze-Sturm U, Auer I, Ahrens F, Brinkmann F
EUROSURVEILLANCE. 2018;23(12):4-9.

Hypereosinophilic Syndrome After Liver Transplantation: A Case Report and a Review of the Literature
Aulbert W, Kobbe R, Breuer C, Briem-Richter A, Schäfer H, Brinkert F, Dettmar A, Kemper M, Grabhorn E
TRANSPLANTATION. 2017;101(5):e166-e169.

Evolution of disease activity and biomarkers on and off rapamycin in 28 patients with autoimmune lymphoproliferative syndrome
Klemann C, Esquivel M, Magerus-Chatinet A, Lorenz M, Fuchs I, Neveux N, Castelle M, Rohr J, Bettoni da Cunha C, Ebinger M, Kobbe R, Kremens B, Kollert F, Gambineri E, Lehmberg K, Seidel M, Siepermann K, Voelker T, Schuster V, Goldacker S, Schwarz K, Speckmann C, Picard C, Fischer A, Rieux-Laucat F, Ehl S, Rensing-Ehl A, Neven B
HAEMATOLOGICA. 2017;102(2):e52-e56.

Case report - atypical hemolytic uremic syndrome triggered by influenza B
Kobbe R, Schild R, Christner M, Oh J, Loos S, Kemper M
BMC NEPHROL. 2017;18(1):96.

Targeted Gene Panel Sequencing for Early-onset Inflammatory Bowel Disease and Chronic Diarrhea
Petersen B, August D, Abt R, Alddafari M, Atarod L, Baris S, Bhavsar H, Brinkert F, Buchta M, Bulashevska A, Chee R, Cordeiro A, Dara N, Dückers G, Elmarsafy A, Frede N, Galal N, Gerner P, Glocker E, Goldacker S, Hammermann J, Hasselblatt P, Havlicekova Z, Hübscher K, Jesenak M, Karaca N, Karakoc-Aydiner E, Kharaghani M, Kilic S, Kiykim A, Klein C, Klemann C, Kobbe R, Kotlarz D, Laass M, Leahy T, Mesdaghi M, Mitton S, Neves J, Öztürk B, Pereira L, Rohr J, Restrepo J, Ruzaike G, Saleh N, Seneviratne S, Senol E, Speckmann C, Tegtmeyer D, Thankam P, van der Werff Ten Bosch J, von Bernuth H, Zeissig S, Zeissig Y, Franke A, Grimbacher B
INFLAMM BOWEL DIS. 2017;23(12):2109-2120.

Plasma cell deficiency in human subjects with heterozygous mutations in Sec61 translocon alpha 1 subunit (SEC61A1)
Schubert D, Klein M, Hassdenteufel S, Caballero-Oteyza A, Yang L, Proietti M, Bulashevska A, Kemming J, Kühn J, Winzer S, Rusch S, Fliegauf M, Schäffer A, Pfeffer S, Geiger R, Cavalié A, Cao H, Yang F, Li Y, Rizzi M, Eibel H, Kobbe R, Marks A, Peppers B, Hostoffer R, Puck J, Zimmermann R, Grimbacher B
J ALLERGY CLIN IMMUN. 2017.

The Extended Clinical Phenotype of 26 Patients with Chronic Mucocutaneous Candidiasis due to Gain-of-Function Mutations in STAT1
Depner M, Fuchs S, Raabe J, Frede N, Glocker C, Doffinger R, Gkrania-Klotsas E, Kumararatne D, Atkinson T, Schroeder H, Niehues T, Dückers G, Stray-Pedersen A, Baumann U, Schmidt R, Franco J, Orrego J, Ben-Shoshan M, McCusker C, Jacob C, Carneiro-Sampaio M, Devlin L, Edgar J, Henderson P, Russell R, Skytte A, Seneviratne S, Wanders J, Stauss H, Meyts I, Moens L, Jesenak M, Kobbe R, Borte S, Borte M, Wright D, Hagin D, Torgerson T, Grimbacher B
J CLIN IMMUNOL. 2016;36(1):73-84.

Common variable immunodeficiency, impaired neurological development and reduced numbers of T regulatory cells in a 10-year-old boy with a STAT1 gain-of-function mutation
Kobbe R, Kolster M, Fuchs S, Schulze-Sturm U, Jenderny J, Kochhan L, Staab J, Tolosa E, Grimbacher B, Meyer T
GENE. 2016;586(2):234-8.

Dolutegravir in breast milk and maternal and infant plasma during breastfeeding
Kobbe R, Schalkwijk S, Dunay G, Eberhard J, Schulze-Sturm U, Hollwitz B, Degen O, Teulen M, Colbers A, Burger D
AIDS. 2016;30(17):2731-2733.

Empfehlungen zur infektiologischen Versorgung von Flüchtlingen im Kindes- und Jugendalter in Deutschland: Stellungnahme der Deutschen Gesellschaft für Pädiatrische Infektiologie, der Gesellschaft für Tropenpädiatrie und Internationale Kindergesundheit und des Berufsverbandes der Kinder- und Jugendärzte
Pfeil J, Kobbe R, Trapp S, Kitz C, Hufnagel M
INTERNIST. 2016;57(5):416-33.

Hyperactive mTOR pathway promotes lymphoproliferation and abnormal differentiation in autoimmune lymphoproliferative syndrome
Rensing-Ehl A, Allgäuer A, Schreiner E, Lorenz M, Rohr J, Klemann C, Fuchs I, Schuster V, von Bueren A, Naumann-Bartsch N, Gambineri E, Siepermann K, Kobbe R, Nathrath M, Arkwright P, Miano M, Stachel K, Metzler M, Schwarz K, Kremer A, Speckmann C, Ehl S, Mackensen A
BLOOD. 2016;128(2):227-38.

Risk of Rotavirus Vaccination for Children with SCID
Klinkenberg D, Blohm M, Hoehne M, Mas Marques A, Malecki M, Schildgen V, Schneppenheim R, Müller I, Schildgen O, Kobbe R
PEDIATR INFECT DIS J. 2015;34(1):114-5.

The ESPID/ESWI Joint Symposium - A strong vote for universal influenza vaccination in children in Europe
Kobbe R
VACCINE. 2015;33(49):6967-9.

Geographically weighted regression of land cover determinants of Plasmodium falciparum transmission in the Ashanti Region of Ghana
Ehlkes L, Krefis A, Kreuels B, Krumkamp R, Adjei O, Ayim-Akonor M, Kobbe R, Hahn A, Vinnemeier C, Loag W, Schickhoff U, May J
INT J HEALTH GEOGR. 2014;13:35.

Hypereosinophiles Syndrom (HES) nach Lebertransplantation
Aulbert W, Breuer C, Oh J, Briem-Richter A, Kobbe R, Ganschow R
2013. Monatszeitschrift Kinderheilkunde. Supplement 2. Aufl. Springer, 95-256.

Ungewöhnlicher Haut- und Skelettbefund – Infantile Myofibromatose
Warlitz C, Kobbe R, Helmke K, Höger P, Singer D
Z GEBURTSH NEONATOL. 2013;217(3):112-3.

Follow-up survey of children who received sulfadoxine-pyrimethamine for intermittent preventive antimalarial treatment in infants
Kobbe R, Hogan B, Adjei S, Klein P, Kreuels B, Loag W, Adjei O, May J
J INFECT DIS. 2011;203(4):556-60.

IL3 variant on chromosomal region 5q31-33 and protection from recurrent malaria attacks
Meyer C, Calixto Fernandes M, Intemann C, Kreuels B, Kobbe R, Kreuzberg C, Ayim M, Ruether A, Loag W, Ehmen C, Adjei S, Adjei O, Horstmann R, May J
HUM MOL GENET. 2011;20(6):1173-81.

Open-source genomic analysis of Shiga-toxin-producing E. coli O104:H4.
Rohde H, Qin J, Cui Y, Li D, Loman N, Hentschke M, Chen W, Pu F, Peng Y, Li J, Xi F, Li S, Li Y, Zhang Z, Yang X, Zhao M, Wang P, Guan Y, Cen Z, Zhao X, Christner M, Kobbe R, Loos S, Oh J, Yang L, Danchin A, Gao G, Song Y, Li Y, Yang H, Wang J, Xu J, Pallen M, Wang J, Aepfelbacher M, Yang R, Consortium E
NEW ENGL J MED. 2011;365(8):718-724.

Multiplicity of Plasmodium falciparum infection following intermittent preventive treatment in infants
Buchholz U, Kobbe R, Danquah I, Zanger P, Reither K, Abruquah H, Grobusch M, Ziniel P, May J, Mockenhaupt F
MALARIA J. 2010;9:244.

Novel human parvovirus 4 genotype 3 in infants, Ghana
Panning M, Kobbe R, Vollbach S, Drexler J, Adjei S, Adjei O, Drosten C, May J, Eis-Hubinger A
EMERG INFECT DIS. 2010;16(7):1143-6.

Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trials
Aponte J, Schellenberg D, Egan A, Breckenridge A, Carneiro I, Critchley J, Danquah I, Dodoo A, Kobbe R, Lell B, May J, Premji Z, Sanz S, Sevene E, Soulaymani-Becheikh R, Winstanley P, Adjei S, Anemana S, Chandramohan D, Issifou S, Mockenhaupt F, Owusu-Agyei S, Greenwood B, Grobusch M, Kremsner P, Macete E, Mshinda H, Newman R, Slutsker L, Tanner M, Alonso P, Menendez C
LANCET. 2009;374(9700):1533-42.

Q fever in young children, Ghana
Kobbe R, Kramme S, Kreuels B, Adjei S, Kreuzberg C, Panning M, Adjei O, Fleischer B, May J
EMERG INFECT DIS. 2008;14(2):344-6.

Simvastatin treatment shows no effect on the incidence of cerebral malaria or parasitemia during experimental malaria
Kobbe R, Schreiber N, May J, Jacobs T
ANTIMICROB AGENTS CH. 2008;52(4):1583-4.

Spatial variation of malaria incidence in young children from a geographically homogeneous area with high endemicity
Kreuels B, Kobbe R, Adjei S, Kreuzberg C, von Reden C, Bäter K, Klug S, Busch W, Adjei O, May J
J INFECT DIS. 2008;197(1):85-93.

Therapeutic and prophylactic effect of intermittent preventive anti-malarial treatment in infants (IPTi) from Ghana and Gabon
May J, Adjei S, Busch W, Gabor J, Issifou S, Kobbe R, Kreuels B, Lell B, Schwarz N, Adjei O, Kremsner P, Grobusch M
MALARIA J. 2008;7:198.

Malaria incidence and efficacy of intermittent preventive treatment in infants (IPTi)
Kobbe R, Adjei S, Kreuzberg C, Kreuels B, Thompson B, Thompson P, Marks F, Busch W, Tosun M, Schreiber N, Opoku E, Adjei O, Meyer C, May J
MALARIA J. 2007;6:163.

Travel-associated Coxiella burnetii infections: three cases of Q fever with different clinical manifestation.
Kobbe R, Kramme S, Gocht A, Werner M, Lippert U, May J, Burchard G
TRAVEL MED INFECT DI. 2007;5(6):374-379.

A randomized controlled trial of extended intermittent preventive antimalarial treatment in infants
Kobbe R, Kreuzberg C, Adjei S, Thompson B, Langefeld I, Thompson P, Abruquah H, Kreuels B, Ayim M, Busch W, Marks F, Amoah K, Opoku E, Meyer C, Adjei O, May J
CLIN INFECT DIS. 2007;45(1):16-25.

Chloroquine-resistant malaria in Malawi
Kobbe R, Meyer C, May J
NEW ENGL J MED. 2007;356(8):868; author reply 869.

Immune responses after single-dose sulphadoxine-pyrimethamine indicate underestimation of protective efficacy of intermittent preventive treatment in infants
Schreiber N, Kobbe R, Adjei S, Adjei O, Klinkert M, May J
TROP MED INT HEALTH. 2007;12(10):1157-63.

Seasonal variation and high multiplicity of first Plasmodium falciparum infections in children from a holoendemic area in Ghana, West Africa
Kobbe R, Neuhoff R, Marks F, Adjei S, Langefeld I, von Reden C, Adjei O, Meyer C, May J
TROP MED INT HEALTH. 2006;11(5):613-9.

Editorial: antifolates in prevention of HIV-associated opportunistic infections and in intermittent preventive treatment of malaria in Africa
Kobbe R, Marks F, May J, Meyer C
TROP MED INT HEALTH. 2005;10(4):293-4.

Parasitological rebound effect and emergence of pyrimethamine resistance in Plasmodium falciparum after single-dose sulfadoxine-pyrimethamine
Marks F, von Kalckreuth V, Kobbe R, Adjei S, Adjei O, Horstmann R, Meyer C, May J
J INFECT DIS. 2005;192(11):1962-5.

Letzte Aktualisierung aus dem FIS: 23.12.2024 - 23:32 Uhr